Recurrent Breast Cancer [clinicaltrials_resource:7ed67add73525de272b5106314978784]
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic [clinicaltrials:NCT00003440]Antineoplaston Therapy in Treating Women With Advanced Breast Cancer [clinicaltrials:NCT00003455]Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer [clinicaltrials:NCT00003536]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]clinicaltrials:NCT00004888Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer [clinicaltrials:NCT00005817]Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00006228]Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer [clinicaltrials:NCT00017394]Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00024154]PS-341 in Treating Women With Metastatic Breast Cancer [clinicaltrials:NCT00025584]Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [clinicaltrials:NCT00028496]Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors [clinicaltrials:NCT00028535]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Decitabine in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00030615]7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) [clinicaltrials:NCT00031681]Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00039455]Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00045188]Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer [clinicaltrials:NCT00053339]clinicaltrials:NCT00054028Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer [clinicaltrials:NCT00055861]clinicaltrials:NCT00057941clinicaltrials:NCT00068588Vaccine Therapy in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00071942]Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer [clinicaltrials:NCT00077363]clinicaltrials:NCT00077376clinicaltrials:NCT00079326clinicaltrials:NCT00082810Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00089362]3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer [clinicaltrials:NCT00095888]Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer [clinicaltrials:NCT00096109]Sorafenib in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00096434]FR901228 in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00098397]Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases [clinicaltrials:NCT00098605]clinicaltrials:NCT00118157clinicaltrials:NCT00132002Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer [clinicaltrials:NCT00159458]Ixabepilone and Liposomal Doxorubicin in Treating Women With Advanced Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer or Metastatic Breast Cancer [clinicaltrials:NCT00182767]clinicaltrials:NCT00217399Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine [clinicaltrials:NCT00228358]clinicaltrials:NCT00244881
condition [clinicaltrials_vocabulary:condition]
Recurrent Breast Cancer [clinicaltrials_resource:7ed67add73525de272b5106314978784]
Bio2RDF identifier
7ed67add73525de272b5106314978784
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7ed67add73525de272b5106314978784
identifier
clinicaltrials_resource:7ed67add73525de272b5106314978784
title
Recurrent Breast Cancer
@en
label
Recurrent Breast Cancer [clinicaltrials_resource:7ed67add73525de272b5106314978784]
@en